Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 44.20 |
---|---|
High | 45.40 |
Low | 44.20 |
Bid | 45.20 |
Offer | 47.00 |
Previous close | 44.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.67m |
Free float | 7.98m |
P/E (TTM) | 33.56 |
Market cap | 621.96m USD |
EPS (TTM) | 1.46 USD |
Annual div (ADY) | 0.5391 EUR |
---|---|
Annual div yield (ADY) | 1.19% |
Div ex-date | Aug 20 2024 |
Div pay-date | Aug 30 2024 |
Data delayed at least 15 minutes, as of Oct 11 2024.
More ▼
Announcements
- IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
- IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
- IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
- IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
- IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
More ▼